INTRODUCTIONThe aim of this work was to assess the effect of 2 formulation variables, the pectin type (with different degrees of esterification [DEs]) and the amount of calcium, on drug release from pectin-based matrix tablets. Pectin matrix tablets were prepared by blending indomethacin (a model drug), pectin powder, and various amounts of calcium acetate and then tableting by automatic hydraulic press machine. Differential scanning calorimetry, powder x-ray diffraction, and Fourier transformed-infrared spectroscopy studies of the compressed tablets revealed no drug-polymer interaction and the existence of drug with low crystallinity. The in-vitro release studies in phosphate buffer (United States Pharmacopeia) and tris buffer indicated that the lower the DE, the greater the time for 50% of drug release (T 50 ). This finding is probably because of the increased binding capacity of pectin to calcium. However, when the calcium was excluded, the pectins with different DEs showed similar release pattern with insignificant difference of T 50 . When the amount of calcium acetate was increased from 0 to 12 mg/tablet, the drug release was significantly slower. However, a large amount of added calcium (ie, 24 mg/tablet) produced greater drug release because of the partial disintegration of tablets. The results were more pronounced in phosphate buffer, where the phosphate ions induced the precipitation of calcium phosphate. In conclusion, both pectin type and added calcium affect the drug release from the pectin-based matrix tablets.Hydrophilic polymer matrix systems are widely used in oral controlled drug delivery because of their flexibility to obtain a desirable drug release profile, cost-effectiveness, and broad regulatory acceptance. [1][2][3] The ability of the hydrophilic polymer matrices to release an entrapped drug in aqueous medium and to regulate the release of such drug by control of swelling and cross-linking makes them particularly suitable for controlled-release applications.2 These matrices can be applied for the release of both hydrophilic and hydrophobic drugs and charged solutes. Recently, many controlled-release formulations based on hydrophilic polymer matrices have been developed. [3][4][5][6] Pectins are hydrophilic polysaccharides derived from plant cell walls. They contain linear chains of (1→4) linked α-Dgalacturonic acid residues.7 These uronic acids have carboxyl groups, some of which are naturally presented as methyl esters. The degree of esterification (DE), which is expressed as a percentage of the esterified carboxyl groups, is an important means to classify pectins. High methoxy (HM) pectins (with DE >50%) require a relatively high concentration of soluble solids and a low pH for gel formation. [7][8] Low methoxy (LM) pectins (with DE <50%) form rigid gels by the action of calcium or multivalent cations, which cross-link the galacturonic acid chains. 7 The nontoxicity and the low production costs of pectins make them of great interest for the formulation of controlled-release do...